Kore Private Wealth LLC Uni Qure N.V. Transaction History

Kore Private Wealth LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$35.98 - $47.66 $17,990 - $23,830	-500 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$37.13 - $74.62 $18,565 - $37,310	500 New	500 $36,000
Q2 2019 Aug 14, 2019	SELL	$52.76 - $82.19 $26,380 - $41,095	-500 Closed	0 $0
Q4 2018 May 23, 2019	BUY	$22.8 - $33.93 $11,400 - $16,965	500 New	500 $14,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Kore Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Kore Private Wealth LLC with notifications on news.